Karin P.S. Langenberg
Impact in
- Genetics top 10%
- Glioma Diagnosis and Treatment
-
- Ubiquitin and proteasome pathways
- Genomics and Chromatin Dynamics
- Epigenetics and DNA Methylation
- Chromatin Remodeling and Cancer
- Histone Deacetylase Inhibitors Research
- Cancer-related gene regulation
Papers in
-
- Chromatin Remodeling and Cancer 4
- Protein Degradation and Inhibitors 3
- Cancer therapeutics and mechanisms 2
-
- Neuroblastoma Research and Treatments 9
- Co-authors
- C. Peter Verrijzer (4 shared papers)Albert J. R. Heck (2 shared papers)Jeroen Krijgsveld (2 shared papers)Yuri M. Moshkin (3 shared papers)Jan A. van der Knaap (2 shared papers)François Karch (1 shared paper)Arnoud J. Kal (1 shared paper)Martin J. van den Bent (1 shared paper)
- Journals
- Molecular and Cellular Biology (3 papers)Cancers (2 papers)Cancer (1 paper)JAMA Network Open (1 paper)Pediatric Blood & Cancer (1 paper)
- Partner nations
- NetherlandsCanadaGermany
In The Last Decade
Karin P.S. Langenberg
17 papers receiving 752 citations
Peers
Comparison fields: 5 of 67
- Genetics 158
- Molecular Biology 562
- Cancer Research 106
- Aging 10
- Oncology 105
Countries citing papers authored by Karin P.S. Langenberg
This map shows the geographic impact of Karin P.S. Langenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin P.S. Langenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin P.S. Langenberg more than expected).
Fields of papers citing papers by Karin P.S. Langenberg
This network shows the impact of papers produced by Karin P.S. Langenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin P.S. Langenberg. The network helps show where Karin P.S. Langenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Karin P.S. Langenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 207 | |
| 2 | 2003 | 160 | |
| 3 | 2004 | 149 | |
| 4 | 2008 | 63 | |
| 5 | 2009 | 59 | |
| 6 | 2021 | 29 | |
| 7 | 2021 | 24 | |
| 8 | 2023 | 19 | |
| 9 | 2014 | 15 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 8 | |
| 12 | 2023 | 7 | |
| 13 | 2020 | 7 | |
| 14 | 2020 | 3 | |
| 15 | 2023 | 1 | |
| 16 | 2017 | 1 | |
| 17 | 2019 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2024 | 0 | |
| 20 | 2021 | 0 |
About Karin P.S. Langenberg
Karin P.S. Langenberg is a scholar working on Molecular Biology, Neurology, Pathology and Forensic Medicine, Cancer Research and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 763 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (9 papers), Chromatin Remodeling and Cancer (4 papers), Protein Degradation and Inhibitors (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Cancer therapeutics and mechanisms (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Genetics (158 citations), Molecular Biology (562 citations), Cancer Research (106 citations), Aging (10 citations) and Oncology (105 citations). Karin P.S. Langenberg has collaborated with scholars based in Netherlands, Canada and Germany. Frequent co-authors include C. Peter Verrijzer, Albert J. R. Heck, Jeroen Krijgsveld, Yuri M. Moshkin, Jan A. van der Knaap, François Karch, Arnoud J. Kal, Martin J. van den Bent, Robert B. Jenkins and Johan M. Kros. Their work appears in journals such as Molecular and Cellular Biology, Cancers, Cancer, JAMA Network Open and Pediatric Blood & Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.